Search for: "Teva Pharmaceuticals" Results 861 - 880 of 1,429
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Oct 2011, 7:40 am by Phil
Sepracor, now known as Sunovion Pharmaceuticals, requested the PTO to re-examine these patents, which now has been completed. [read post]
20 Oct 2011, 5:36 am by Tom Lamb
This Aetna letter may raise a question for some people: Why would a health insurance company such as Aetna want a person to sue a drug company like Bayer or Teva? [read post]
19 Oct 2011, 3:30 am by Marie Louise
(IPBiz) US: Patent protection for the BRCA1 gene and genetic diagnostic methods in the USA: AMP v USPTO (JIPLP) US: Marking with an unenforceable patent does not create intent to deceive: Hollander v Hospira (Chicago Intellectual Property Law Blog) US: Regenerative Sciences lawsuit update and FDA’s attempt to broaden the definition of “interstate commerce”: USA v Regenerative Sciences (FDA Law Blog)   Products Embeda (Morphine, Naltrexone) – US: Pfizer, Alpha… [read post]
17 Oct 2011, 5:24 am by Walter Olson
“Convicted King of Class Actions Builds Aviary, Regrets Nothing” [Lerach, Bloomberg profile] Teva/Baxter suits: Latest Nevada you-made-the-vials-too-big propofol verdict makes no more sense than first [Glenn Lammi, Forbes; Ted at PoL] EPA malicious prosecution in Hubert Vidrine case won’t be “isolated” unless we change our thinking [Ken at Popehat] Title IX coordinator training: “How federal regulations are making college ‘risk… [read post]
12 Oct 2011, 7:17 am by Ted Frank
We've previously discussed a series of lawless cases in Nevada against Teva Pharmaceuticals and Baxter Healthcare over the misuse of propofol by the Desert Shadow Endoscopy Center, whose ludicrously unsanitary practices caused dozens of cases of hepatitis C: May 19, 2010; May 24, 2010; ; June 17, 2010; March 4. [read post]
11 Oct 2011, 2:19 pm by eithurburn@getnicklaw.com
Teva Pharmaceuticals, who agreed to purchase Cephalon for $6.8 billion, did not express concern. [read post]
11 Oct 2011, 8:44 am
It is third verdict for Teva Pharmaceutical Industries Ltd. and Baxter International Inc. over a hepatitis outbreak related to Propofol. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
5 Oct 2011, 3:44 am by Marie Louise
  Highlights this week included: Angiomax (Bivalirudin) – Teva drops attempts to void Angiomax patents, but will supply Medicines Company with the active ingredient (The IP Factor) (GenericsWeb) US: Rep. [read post]
5 Oct 2011, 3:44 am by Marie Louise
  Highlights this week included: Angiomax (Bivalirudin) – Teva drops attempts to void Angiomax patents, but will supply Medicines Company with the active ingredient (The IP Factor) (GenericsWeb) US: Rep. [read post]
2 Oct 2011, 9:03 am
The speaker is Dr Galit Gonen (who heads up the European patent litigation team at Teva Pharmaceuticals) and her subject is "Linkages between legal and marketing theories regarding secondary patents for pharmaceuticals". [read post]
20 Sep 2011, 6:35 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734 (S.D. [read post]
16 Sep 2011, 8:17 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 U.S. [read post]
7 Sep 2011, 9:59 pm by Patent Docs
By James DeGiulio -- Teva's Patents Covering Copaxone Upheld in Infringement Suit Mylan failed in its efforts to dismiss Teva's patent suit over the multiple-sclerosis drug Copaxone when the patents directed to the active pharmaceutical ingredient (API) in the drug, glatiramer acetate, were upheld as valid. [read post]
  The AstraZeneca settlement follows settlements by other defendants to the lawsuit, including Teva Pharmaceuticals, Barr Laboratories, Inc., and Sandoz, Inc. [read post]
31 Aug 2011, 2:30 am by Marie Louise
  General The patentability black hole (Patent Law Practice Center) Notes on the new Wikileaks cables – Pfizer asks US embassy to intervene in Philippines drug prices debate, US-Thailand FTA concerns, etc (KEI) 240 Wikileaks cables on pharmaceutical data exclusivity (KEI) 2,446 Wikileaks cables mentioning the search term “pharmaceutical” (KEI) Australia: Gene Patent Bill update – Senate inquiry extended… again (Patentology) EU: Post-Medeva… [read post]